Company Overview
About Microbiotica
Microbiotica applies genomics and machine learning to map the gut microbiome's causal role in disease, then develops live biotherapeutic products (LBPs) targeting the specific bacterial strains responsible. The company's Reference Microbiome database — built from thousands of patient samples — is the world's most comprehensive catalog of gut bacteria linked to disease outcomes, providing a systematic foundation for microbiome drug discovery.
Business Model & Competitive Advantage
Spun out of the Wellcome Sanger Institute in 2017, Microbiotica has demonstrated that specific microbiome compositions predict and mediate response to cancer immunotherapy (checkpoint inhibitors). Its lead programs aim to convert non-responders into responders by supplementing their microbiome with beneficial bacterial strains. Phase 1/2 trials in combination with anti-PD1 therapies are underway.
Competitive Landscape 2025–2026
The $105M Series C in 2025 will fund clinical advancement of Microbiotica's oncology and inflammatory bowel disease (IBD) programs. As the microbiome field matures from correlation to causation, Microbiotica's database advantage and clinical momentum position it as a leader in what could become a multi-billion dollar therapeutic category.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Microbiotica is an emerging player bringing innovative solutions to the BioTech market.
Growth Stage
Microbiotica has achieved $105M in revenue, demonstrating strong product-market fit.
Frequently Asked Questions
Not So Random Others
a2z Radiology AI
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disea
Adept AI
Adept AI was founded in 2022 by a team of former OpenAI, DeepMind, and Google Brain researchers to build AI that can take actions on computers — navigating software interfaces, filling forms, and exec
Plenty
Plenty is a San Francisco-based indoor vertical farming company that uses AI, machine learning, and robotics to grow leafy greens and other produce in controlled indoor environments. The company has r
80 Acres Farms
80 Acres Farms is a commercial-scale indoor vertical farming company that, following its merger with Soli Organic, operates the largest indoor farming network in North America. The company raised $115
Duckie
Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit
Honda
Honda Motor Co., Ltd. is a Japanese multinational mobility conglomerate founded in 1948 by Soichiro Honda and Takeo Fujisawa in Hamamatsu, Japan. Starting as a motorcycle manufacturer, Honda expanded
Compare Microbiotica with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Microbiotica? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Microbiotica Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Microbiotica vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →